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236 WOMEN & HEALTH
ABSTRACT. Objectives: Vulnerability to HIV and Hepatitis C virus
(HCV) infection for indigenous populations worldwide must be
contextualized in experiences of current and past trauma. Aboriginal
women entrenched in poverty face further gender-specific harms
which place them at increased risk for HIV infection.
Methods: This study was cross-sectional and based on a
community-based sample of Aboriginal young people (Métis, Abo-
riginal, First Nations, Inuit, and non-status Indians) between the
ages of 14 and 30 years who used injection or non-injection non-
cannabis illegal drugs (street drugs) in the previous month. Between
October 2003 and July 2005, 543 participants living in either
Vancouver or Prince George, Canada, were recruited by word of
mouth, posters, and street outreach. Young people in the study
completed a questionnaire administered by Aboriginal interviewers.
Female participants (n D 262) were compared to male participants
(n D 281) with respect to sociodemographics, trauma, sexual
risk variables, and drug use patterns. Trained nurses drew blood
samples for HIV and HCV antibodies and provided pre- and post-test
counseling.
Results: Proportions positive for HIV and HCV were significantly
higher among young women. HIV was 13.1% [9.5, 17.7] in women
compared to 4.3% [2.5, 7.4] in men, and HCV was 43.6% [37.6,
49.8] in women as compared to 25.4% [20.5, 30.9] in men. When the
analysis was restricted to young people who reported injection drug
use, the proportions positive for HIV and HCV remained significantly
higher among young women. Experiences of forced sex were reported
by 70% of young women compared to 29% of young men, p < 0:001,
while the median age of first forced sex was 6-years-old for both men
and women.
Discussion: The results of the final model indicated that HIV
had been associated with residing in Vancouver, having injected
for longer, and sexual abuse, but not being female. However, this
gendered analysis demonstrated that a greater proportion of young
women were experiencing sexual abuse, and sexual abuse was asso-
ciated with HIV positive status. Harm reduction and drug treatment
programs are urgently required that target women at a young age
and address complex traumatic experiences associated with childhood
sexual abuse.
KEYWORDS. HIV, AIDS, hepatitis C, HCV, Aboriginal, women,
gender, injection, drug use, Canada, sex work, sexual abuse
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Mehrabadi et al. 237
INTRODUCTION
Aboriginal leadership and AIDS organizations in Canada are deeply
concerned about increasing rates of HIV and HCV among young
Aboriginal men and women and the role of historic trauma in height-
ening their vulnerability (Barlow, 2003; Pearce et al., 2008). In the
past decade, the rate of HIV infection among Aboriginal people has
grown more rapidly than in any other single ethnic group in Canada.
Although Aboriginal people comprise only 3.3% of the Canadian
population, as of 2005, an estimated 3,600 to 5,100 Aboriginal people
were living with HIV in Canada, representing 7.5% of all HIV infec-
tions and 22% of new infections. Injection drug use is the primary risk
factor for HIV among Aboriginal people, accounting for 58.9% of all
infections between 1998 and 2005 (Public Health Agency of Canada,
2006). Limited research indicates that before 1992, in provinces with
reported ethnicity data, 9.7% of Aboriginal AIDS cases were among
people under the age of 30. In 2002, however, 41.2% of the Abo-
riginal cases were in this age group; the majority of infections were
attributed to injection drug use. National HIV/AIDS surveillance data
indicate that Aboriginal women in Canada have been disproportion-
ately affected by HIV when compared to non-Aboriginal women.
Between 1998–2005, Aboriginal women in Canada comprised 47.4%
of all HIV positive test reports among Aboriginal people, compared
to 20.5% among non-Aboriginal people (Public Health Agency of
Canada, 2006). At a time when indigenous people’s vulnerability
to HIV infection is becoming recognized worldwide (CDC, 2005;
Wright, Giele, Dance, & Thompson, 2005), a better understanding of
the processes and factors that cause drug-related harm among young
Aboriginal women is urgently required.
Residential Schools, the Child Welfare System,
and HIV Risk
Indigenist scholars have suggested that any research regarding the
HIV-related vulnerability of Aboriginal young people, particularly
girls and women, must be informed by discussion of the histori-
cal legacy of colonization, including forced removal from traditional
lands, economic deprivation, cultural genocide, and, in particular, the
histories of the residential school and child welfare systems (Red Road
HIV/AIDS Network, 2006; Simoni, Sehgal, & Walters, 2004; Wesley-
Esquimaux & Smolewski, 2004). The residential school system was
arguably the most destructive Canadian institution to Aboriginal com-
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238 WOMEN & HEALTH
munities and families. Operating in a church-state partnership from
1874 to 1996, the residential school system forcibly removed over
100,000 children from their homes in an effort to “kill the Indian” in
the child for the sake of Christian civilization (Milloy, 1999, p. xv).
In contrast to traditional Aboriginal ways of learning and parenting,
the missionary teachers in residential schools taught students to be
ashamed of their culture, history, languages, and ways of life (Milloy,
1999, p. 299). In addition, Aboriginal children in residential schools
were subjected to many forms of abuse, of which sexual abuse was
the most pervasive. In the aftermath of their experience, students who
attended residential schools often brought back to their communities
what they had learned about control and abuse, and inflicted this upon
their own children (Barlow, 2003; Pearce et al., 2008). Currently, an
estimated 35,000 survivors of the residential school system are living
in the province of British Columbia (Provincial Health Officer, 2002).
According to the 1998 British Columbia Children’s Commission An-
nual Report, rates of child maltreatment within Aboriginal families are
related to intergenerational trauma, as Aboriginal parents and grand-
parents are still coping with the effects of residential schools (1999,
p. 7; Pearce et al., 2008). Indeed, intergenerational trauma, defined by
indigenous scholars as the transmission of a collective emotional and
psychological injury over the lifespan and across generations among
Aboriginal people, continues to affect the health and well-being of
young Aboriginal men and women (RCAP, 1996; Yellow Horse &
Brave Heart, 2004).
The era of the residential school system was intersected by another
era of assimilationist strategy aimed at Aboriginal children. Beginning
in 1951, the federal government delegated the health, welfare, and
educational services of Aboriginal people to each province. Economic
incentives were provided to child welfare agencies for each child ap-
prehended; conversely, basic housing and childcare were not available
to Aboriginal families (Fournier & Crey, 1997, pp. 82–84). By the late
1960s, Aboriginal children comprised 30–40% of all legal wards but
only 4% of the national population (Fournier & Crey, 1997, p. 83).
Currently in BC, an estimated 49% of children under government
care and 41% of youth in detention centers are Aboriginal (Latimer
& Foss, 2004; Ministry of Health, 2006).
Purpose of Study
Historically, much of HIV research, particularly with people who
use drugs, has been driven by a need to better understand the rela-
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Mehrabadi et al. 239
tionship between gender (defined in this article as female vs. male)
and HIV infection. The purpose of this study was to compare sociode-
mographics, drug use patterns, injection practices, sexual experiences,
lifetime and historical trauma, and HIV and HCV prevalence between
young Aboriginal men and women using illegal drugs in two urban
settings. Study locations were in Vancouver’s downtown east side
and Prince George, a mining and forestry town in northern British
Columbia. According to the 2001 census, the proportion of Aboriginal
people living in Vancouver was 36,860 (1.9% of Vancouver), while
7,960 resided in Prince George (9.4% of Prince George) (Statistics
Canada, 2001). In 2001, 6,885 Aboriginal young men and 7,195
Aboriginal young women between ages 15–34 years resided in the
Northern Health Authority, in which Prince George is located, and
3,900 Aboriginal young men and 3,775 Aboriginal young women in
this age group resided in the Vancouver Coastal Health Authority
(B.C. Stats, 2001). In this study, Aboriginal ethnicity was based upon
self-reported identification as a descendent of the First Peoples of
Canada, and was inclusive of status and non-status First Nations,
Métis, and Inuit (for details on the definitions, see RCAP, 1996,
pp. 1–22). To our knowledge, this is the only prospective study of
young at-risk indigenous peoples of its kind in North America.
METHODS
Ethics
The Cedar Project Study followed the guidelines provided in the
Canadian Tri-Council Policy Statement: Ethical Conduct for Research
Involving Human Subjects, and paid particular attention to section 6.0
pertaining to research involving Aboriginal participants. Our Abo-
riginal collaborators, including Aboriginal AIDS service organiza-
tions, were involved in the conception, design, and implementation
of the Cedar Project. The Cedar Project Partnership reviewed the
results of this analysis and approved this manuscript for publication.
In addition, the study was approved by the University of British
Columbia/Providence Health Care Research Ethics Board.
Study Design and Sample
This analysis used baseline data from the Cedar Project, an ongoing
prospective cohort study involving 543 Aboriginal young people who
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240 WOMEN & HEALTH
resided in Vancouver and Prince George. Eligibility criteria stipu-
lated that participants were between 14 and 30 years of age, self-
identified as Aboriginal, and had smoked illegal drugs in the last
week or injected illegal drugs in the last month, including crystal
methamphetamine, crack-cocaine, heroin, or cocaine. Saliva screens
(ORALscreen®, Avitar Onsite Diagnostics) were used to confirm drug
use. Participants provided written informed consent. Participants in
both cities were recruited through referral by healthcare providers,
community outreach, and by word of mouth between October 2003
and July 2005. The majority of participants in the study were recruited
by word of mouth (39%) and outreach staff (32%). Other methods of
recruitment consisted of posters on street corners and postering in
a variety of community organizations frequented by both men and
women. The recruitment goal in each city was approximately 300
participants. This was based on sample size calculations using a two-
sided alpha level of 0.05 and a power of 80% to detect risk factors for
prevalent HIV infection, with an odds ratio as low as 1.5, provided
the risk factor was present in at least 20% of participants. The power
for detecting associations for HCV infection was higher because its
higher incidence and prevalence was expected to result in a larger
sample who were HCV positive.
All participants met with one Aboriginal study coordinator who
explained procedures, sought informed consent, and confirmed study
eligibility. In the consenting process, all participants were informed
of the limitations of research confidentiality, including communicable
disease reporting, self-harm involvement, and child welfare legislation
regarding current sexual abuse. Study participants always had the
opportunity to be interviewed by an Aboriginal person, and, since con-
fidentiality issues were a concern, particularly in smaller communities,
participants were always given a choice to be interviewed by someone
they trusted from the research team. Venous blood samples were
drawn and tested for HIV and hepatitis C antibodies, and interviewers
were blinded to the HIV and hepatitis C status of the participants. All
eligible participants had private interviews, including pre- and post-
test counseling with trained nurses; participants were requested to re-
turn for their HIV/HCV sero-status test result at which time referral for
HIV/AIDS and hepatitis C care was provided. We actively encouraged
participants to return for their results; however, receiving a result was
not a requirement of participating in the study. Participants were given
a $20 stipend at each study visit as compensation for their time and
to facilitate transportation. When requested, study personnel secured
emotional and physical support, including access to traditional healing
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Mehrabadi et al. 241
support, addictions treatment, and secure housing. All participants
who completed the baseline questionnaire from October 2003 to July
2005 were included in this analysis.
Measures
Point estimates of proportions positive for HIV and HCV and
95% confidence intervals were computed separately for females and
males, and estimates were stratified by injection drug use. Variables
of interest included socio-demographic characteristics, sexual expe-
riences, drug use patterns, and utilization of services. We obtained
information related to the legacy of abuse and intergenerational trauma
(Fournier & Crey, 1997), such as ever having been in the foster
care system (yes vs. no) and having biological parents who attended
residential schools (yes vs. no/unsure). “Sexual abuse” was defined
for participants as any sexual activity that participants were forced
or coerced into, including childhood sexual abuse, molestation, rape,
and sexual assault. Interviewers gave this definition to participants
prior to asking the question: “Have you ever been forced to have
sex against your will and/or been molested” (yes vs. no, unsure/can’t
remember classified as missing). Participants were also asked if they
had attempted to commit suicide in their lifetime and/or in the prior
six months (yes vs. no).
Stable housing was defined as living in a house or apartment.
Unstable housing was defined as living arrangements that included
single room occupancy hotels (SROs), transitional living arrangements
(“couch surfing”), and homelessness. Living on the street was defined
as having lived on the streets for at least three nights during your
lifetime (yes vs. no), and ever having been incarcerated was defined
as ever being placed in prison or jail overnight or longer (yes vs.
no). Measures used previously in the Vancouver Injection Drug User
Study (VIDUS) on sexual experiences and drug use patterns were
adapted for use in the baseline questionnaire (Spittal et al., 2006).
Sexual risk variables included unsafe sex with regular and casual sex
partners and with clients. Unsafe sex was defined as not always using a
condom during anal and/or vaginal sex. Regular partners were defined
as those partners with whom the sexual relationship lasted for over
three months. Casual partners were defined as those partners with
whom sexual relationships lasted less than three months. Clients were
defined as partners with whom sex was traded for drugs, food, or
money.
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242 WOMEN & HEALTH
As our sample contained a greater proportion of females who
reported injecting drugs, injection drug use variables were restricted
to the 298 participants who reported injecting drugs in their life-
times (yes vs. no). Opiate use was defined by the use of any of
the following injection drugs: morphine, heroin, methadone, Talwin®
(pentazocine with naloxone) and/or Dilaudid® (hydromorphone hy-
drochloride). Binging was defined for users as periods in which drugs
were injected more frequently than usual. All participants were asked
if they had ever overdosed (yes vs. no) and if they had visited the fixed
or mobile needle exchange in the past six months. High-risk injection
variables included ever needing help injecting, having needed help
injecting in the past 6 months, ever having used a syringe someone
else had already used, and using a syringe someone else had used in
the past six months (each yes/no).
Univariate Analysis
Initially, a descriptive analysis was performed for the entire study
sample. Pearson’s chi-square and Fisher’s exact test (if one or more
expected counts were less than five) were applied to compare cate-
gorical variables, while Wilcoxon rank sum test was used to compare
continuous variables. SPSS (Windows 11.0 version) and S-plus (Win-
dows 6.2 version) statistical software were used to run these analyses.
For univariate analyses, odds ratios for the association between var-
ious risk factors and gender were calculated. Because of the potential
influence of location (Prince George vs. Vancouver), the latter analy-
ses were stratified over location and summarized using Mantel Haen-
szel statistical methods. For test of homogeneity, a cut-off p-value of
0.05 was used. Summary odds ratios and the corresponding 95% CIs
were estimated for only those variables that provided a p-value greater
than 0.05 in homogeneity test. All p-values were two-sided.
Multivariable Analysis
The multivariable analysis was restricted to participants who re-
ported ever injecting drugs. Multivariable logistic regression was used
to model independent variables that were significant in univariate
analyses at the p D 0:05 level and for their association in literature
with HIV infection. Three different models were built incrementally
to model the association of gender with HIV infection. Location, dura-
tion of injection, and sexual abuse were chosen due to their association
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Mehrabadi et al. 243
with HIV in bivariate analyses (Table 1) and the theoretical basis for
their association with HIV. Model 1 included gender adjusted for being
located in Vancouver compared to Prince George, model 2 added
duration of injection (as a continuous variable), and model 3 added
sexual abuse. Interaction terms were tested between gender and sexual
abuse, and gender and location, but were not found to be significant.
RESULTS
Demographics and Traumatic Experiences
The mean age at study enrollment was slightly lower for women
(Table 2). Young women were more likely to be married/common law
rather than single and nearly twice as likely to identify as bisexual
or gay. Legally paid employment in the last six months was lower
among females, although employment was low overall.
Women were almost six times more likely to have been sexually
abused in their lifetimes, with a mean age of first abuse of approxi-
mately 7.5 years. Women were less likely to live in unstable housing in
the previous six months and also to have lived on the streets. Women
had lower levels of employment and were more likely to have been on
welfare. A significantly higher proportion of men had been in prison
or detention center overnight or longer in the previous six months,
and significantly more males had been detained in their lifetime. A
higher proportion of women had ever attempted suicide, although the
proportions were remarkably high for both groups. Women were also
more likely to use crack cocaine and to inject drugs.
Sex Work, Unsafe Sex, Regular vs. Casual Partners
Women were more likely to have been paid for sex in their lives
and in the prior six months, more so in Prince George than Vancouver
(Table 3). Women had much higher numbers of clients in the prior
six months and were more likely to have unsafe sex with them.
Significantly more women had regular partners of the opposite sex,
while unprotected sex with regular partners was high for both men and
women. Significantly more men had casual partners of the opposite
sex. Women were less likely than men to have unsafe sex with a
casual partner in Prince George, but more likely in Vancouver.
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TABLE 1. Univariate and Multivariate Modeling for HIV Prevalence Restricted to Participants Who Reported
Ever Injecting (n D 298)
HIV
Positive
n (%)
HIV
Negative
n (%)
Unadjusted
OR
(95% CI)
Adjusted OR
Model 1
Adjusted OR
Model 2
Adjusted OR
Model 3
(n D 293)
Gender
Male 11 (28) 119 (46) Reference Reference Reference Reference
Female 28 (72) 140 (54) 2.16 (1.03, 4.53) 2.15 (1.02, 4.52) 2.06 (0.95, 4.46) 1.55 (0.69, 3.49)
Location
Prince George 10 (26) 114 (44) Reference Reference Reference Reference
Vancouver 29 (74) 145 (56) 2.28 (1.07, 4.87) 2.26 (1.05, 4.86) 2.30 (1.04, 5.07) 2.68 (1.19, 6.05)
Median duration
of injection
Months (SD) 83.1 (44.2) 43.3 (44.2) 1.02 (1.01, 1.02) — 1.02 (1.01, 1.02) 1.02 (1.01, 1.03)
Sexual abuse
No 9 (23) 123 (48) Reference — — Reference
Yes 30 (77) 131 (52) 3.13 (1.43, 6.86) — — 3.24 (1.37, 7.66)
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TABLE 2. Comparisons of Demographic Characteristics and Traumatic Events Between All Female (n D 260) and
Male (n D 278) Cedar Participants
Prince George Vancouver
Variable
Males
n (%)
Females
n (%)
Odds Ratio
(95% CI)
Males
n (%)
Females
n (%)
Odds Ratio
(95% CI)
Test for
Heterogeneity
Summary
Odds Ratio
(95% CI)
p
Value
Mean age at
enrollment visit
(SD)
23.0 (4.4) 21.6 (4.1) 0.9 (0.9, 1.0) 23.8 (3.7) 23.3 (3.7) 1.0 (0.9, 1.0) N/A 1.0 (0.9, 1.0) 0.024
Married/common
law vs. single
20 (16) 40 (36) 3.1 (1.7, 5.7) 25 (17) 38 (26) 1.7 (1.0, 3.0) 0.170 2.2 (1.5, 3.4) <0.001
Bisexual or gay
(two-spirited)
2 (2) 16 (14) 10.7 (2.4, 47.6) 19 (13) 22 (15) 1.2 (0.6, 2.2) 0.003 — —
Either biological
parent ever
attended
residential school
57 (45) 51 (46) 1.0 (0.6, 1.7) 75 (51) 61 (41) 0.7 (0.4, 1.1) 0.239 0.8 (0.6, 1.2) 0.286
Ever taken from
biological parent
74 (57) 77 (69) 1.7 (1.0, 2.9) 96 (64) 99 (66) 1.1 (0.7, 1.8) 0.237 1.3 (0.9, 1.9) 0.119
Mean age first
taken from
biological parents
(SD)
6.0 (3.9) 5.4 (3.8) 1.0 (0.9, 1.1) 4.5 (4.2) 5.4 (4.2) 1.1 (1.0, 1.1) N/A 1.0 (1.0, 1.1) 0.604
Ever sexually
abused
36 (29) 82 (75) 7.3 (4.1, 13.0) 42 (30) 96 (66) 4.7 (2.8, 7.7) 0.246 5.7 (3.9, 8.2) <0.001
Mean age of first
sexual abuse (SD)
6.9 (3.6) 8.2 (4.6) 1.1 (1.0, 1.2) 7.1 (4.0) 6.8 (4.4) 1.0 (0.9, 1.1) N/A 1.0 (1.0, 1.1) 0.455
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TABLE 2 (continued)
Prince George Vancouver
Variable
Males
n (%)
Females
n (%)
Odds Ratio
(95% CI)
Males
n (%)
Females
n (%)
Odds Ratio
(95% CI)
Test for
Heterogeneity
Summary
Odds Ratio
(95% CI)
p
Value
Did not complete
high school1
109 (85) 101 (91) 1.8 (0.8, 4.0) 111 (75) 119 (82) 1.5 (0.8, 2.6) 0.719 1.6 (1.0, 2.5) 0.058
Unstable housing
(previous six
months)
44 (34) 32 (29) 0.8 (0.4, 1.4) 94 (68) 76 (56) 0.6 (0.4, 1.0) 0.421 0.7 (0.5, 1.0) 0.038
Ever been on the
street (>3 nights)
75 (58) 55 (50) 0.7 (0.4, 1.2) 122 (83) 111 (75) 0.6 (0.3, 1.1) 0.635 0.7 (0.5, 1.0) 0.033
Employed in last 6
months
40 (31) 11 (10) 0.3 (0.1, 0.5) 26 (17) 8 (5) 0.3 (0.1, 0.6) 0.870 0.3 (0.2, 0.4) <0.001
On welfare last 6
months
46 (36) 56 (51) 1.8 (1.1, 3.1) 80 (54) 84 (56) 1.1 (0.7, 1.8) 0.156 1.4 (1.0, 2.0) 0.060
Ever detained by
police
119 (92) 80 (72) 0.2 (0.1, 0.5) 129 (87) 101 (68) 0.3 (0.2, 0.6) 0.405 0.3 (0.2, 0.4) <0.001
Been in jail, prison,
or detention center
overnight or longer
(previous six
months)
92 (71) 53 (48) 0.4 (0.2, 0.6) 121 (81) 93 (62) 0.4 (0.2, 0.7) 0.907 0.2 (0.3, 0.6) <0.001
Ever attempted
suicide
42 (33) 52 (47) 1.8 (1.1, 3.0) 43 (29) 57 (38) 1.5 (0.9, 2.5) 0.647 1.7 (1.2, 2.4) 0.006
Frequent crack use
(last 6 months)
51 (40) 63 (57) 2.0 (1.2, 3.4) 74 (50) 105 (71) 2.4 (1.5, 3.9) 0.603 2.2 (1.6, 3.2) <0.001
Injection drug use
(ever)
56 (43) 68 (61) 2.1 (1.2, 3.5) 74 (50) 100 (67) 2.1 (1.3, 3.3) 0.992 2.1 (1.5, 2.9) <0.001
Note: Participants who answered unsure were grouped as ‘‘no’’ answers.
1Analysis restricted to participants age 19 or older, n D 447.
2
4
6
D
o
w
n
l
o
a
d
e
d
 
b
y
 
[
U
n
i
v
e
r
s
i
t
y
 
o
f
 
W
e
s
t
e
r
n
 
O
n
t
a
r
i
o
]
 
a
t
 
0
7
:
0
5
 
1
6
 
D
e
c
e
m
b
e
r
 
2
0
1
2
 
TABLE 3. Comparisons of Sexual Experiences Between All Female (n D 260) and Male (n D 278) Cedar Participants
Prince George Vancouver
Variable
Males
n (%)
Females
n (%)
Odds Ratio
(95% CI)
Males
n (%)
Females
n (%)
Odds Ratio
(95% CI)
Test for
Heterogeneity
Summary
Odds Ratio
(95% CI)
p
Value
Ever been paid for
sex
11 (9) 77 (69) 24.3 (11.6, 50.8) 37 (25) 107 (72) 7.8 (4.5, 12.7) 0.011 — —
Paid for sex (last 6
months)
4 (3) 69 (63) 52.6 (18.1, 153.0) 16 (11) 83 (56) 10.3 (5.6, 19.0) 0.007 — —
Regular partner of
opposite sex
49 (56) 71 (68) 1.7 (0.9, 3.0) 51 (51) 88 (66) 1.9 (1.1, 3.2) 0.764 1.8 (1.2, 2.6) 0.004
Unsafe sex with
regular partners
42 (86) 61 (86) 1.0 (0.4, 2.9) 37 (76) 71 (82) 1.4 (0.6, 4.5) 0.612 1.3 (0.7, 2.4) 0.504
Regular partner
you knew injected
drugs (last 6
months)
11 (23) 21 (32) 1.6 (0.7, 3.7) 16 (31) 19 (23) 0.7 (0.3, 1.4) 0.133 1.0 (0.6, 1.7) 0.952
Regular partner
you knew was HIV
positive (last 6
months)
1 (2) 3 (5) 2.2 (0.2, 22.5) 0 (0) 6 (8) 1.1 (1.0, 1.16) 0.242 6.1 (0.7, 51.0) 0.093
Casual partner of
opposite sex
51 (47) 57 (45) 0.6 (0.4, 1.1) 60 (59) 40 (30) 0.3 (0.2, 0.5) 0.071 0.4 (0.3, 0.6) <0.001
Unsafe sex with
casual partner
26 (53) 13 (28) 0.4 (0.2, 0.8) 28 (46) 21 (54) 1.4 (0.6, 3.1) 0.018 — —
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248 WOMEN & HEALTH
Injection Drug Use
Among participants having used injection drugs in their lifetime
(n D 298), frequent use of any injection category was higher among
women than among men (58% in women as compared to 37% in men,
p < 0:001). The single-drug category in which significantly more
young men reported drug use was frequent intravenous (IV) crystal
methamphetamine, although use was low overall at 11% as compared
to 4%, p D 0:013. Frequent opiate use was significantly higher among
females at 47% as compared to 19%, p < 0:001, as was frequent
speedball use (15% compared to 2%, p < 0:001). Frequent-injection
cocaine use was found to be slightly higher among females (29% as
compared to 22%, p D 0:160), although no significant difference was
detected.
Women were less likely than men to use crystal methamphetamine
but more likely to inject opiates and speedballs. Women were more
likely than men in Prince George to report binges, but less likely
in Vancouver. No significant differences were observed in needle
borrowing, lending, reported barriers to access, or use of fixed nee-
dle exchange sites in the last six months between men and women
(Table 4). Use of the mobile needle exchange in the past six months
was higher among young women. Significantly more women reported
drug overdose in the last six months, and significantly more women
had ever been on methadone maintenance treatment or were currently
on methadone maintenance therapy. No significant difference was
detected in the proportion that had needed help injecting.
Proportion of HIV and HCV Positive by Gender
The proportions positive for HIV and HCV were significantly higher
among females in the study (Table 5), with the exception of HCV
among non-injectors, which occurred in similar proportions among
both men (3.5%) and women (3.4%), p D 1:000. HIV was 4.3%
among males compared to 13.1% in among females, p < 0:001,
and HCV was 25.4% among males compared to 43.6% in all fe-
males, p < 0:001. When the analysis was restricted to young people
who reported injection drug use (IDU), 8.5% of males involved in
IDU were HIV positive and 16.7% of females involved in IDU,
p D 0:037, while HCV positivity was 50.4% among males involved
in IDU and 65.4% among females involved in IDU, p D 0:010.
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TABLE 4. Comparisons of Substance Use Patterns Between Female (n D 170) and Male Cedar Participants (n D
131) Restricted to Participants Who Reported They ‘‘Ever Injected Drugs’’
Prince George Vancouver
Variable
Males
n (%)
Females
n (%)
Odds Ratio
(95% CI)
Males
n (%)
Females
n (%)
Odds Ratio
(95% CI)
Test for
Heterogeneity
Summary
Odds Ratio
(95% CI)
p
Value
Median duration of
injection in months (SD)
53.3 (50.4) 44.9 (44.9) 41.7 (43.0) 54.1 (47.2) — —
Mean age of first
injection (IQR)
19.2 (4.0) 17.0 (3.6) 19.4 (4.2) 18.0 (4.3) — —
Daily IV cocaine use
(previous six months)
17 (30) 26 (39) 1.5 (0.7, 3.2) 12 (16) 23 (23) 1.5 (0.7, 3.3) 0.994 1.5 (0.9, 2.6) 0.124
Daily IV speedball 1 (2) 7 (10) 6.3 (0.8, 3.2) 2 (3) 18 (18) 7.8 (1.8, 34.8) 0.873 7.3 (2.2, 24.8) 0.001
Daily IV opiate use
(morphine, heroin,
methadone, Talwin
and/or Dilaudid)
8 (14) 20 (29) 2.5 (1.0, 6.2) 17 (23) 59 (58) 4.7 (2.4, 9.2) 0.271 3.8 (2.2, 6.4) <0.001
Daily IV crystal use
(previous six months)
2 (4) 1 (1) 0.40 (0.1, 4.6) 12 (16) 5 (5) 0.2 (0.1, 0.8) 0.763 0.3 (0.1, 0.8) 0.014
Daily use of any single
injection drug category
last six months
22 (39) 34 (49) 1.5 (0.8, 3.2) 27 (37) 65 (64) 3.1 (1.7, 5.9) 0.141 2.3 (1.4, 3.7) <0.001
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TABLE 4 (continued)
Prince George Vancouver
Variable
Males
n (%)
Females
n (%)
Odds Ratio
(95% CI)
Males
n (%)
Females
n (%)
Odds Ratio
(95% CI)
Test for
Heterogeneity
Summary
Odds Ratio
(95% CI)
p
Value
Runs or binges with
injection drugs in last 6
months
8 (17) 17 (32) 2.2 (0.9, 5.8) 15 (25) 13 (14) 0.5 (0.2, 1.2) 0.020 — —
Ever overdosed 17 (30) 27 (39) 1.5 (0.7, 3.1) 27 (37) 43 (43) 1.3 (0.7, 2.5) 0.842 1.4 (0.9, 2.2) 0.174
Overdosed past six
months
1 (6) 9 (33) 8.0 (0.9, 70.3) 4 (14) 12 (25) 2.0 (0.6, 6.9) 0.263 3.1 (1.1, 8.8) 0.036
Ever needed help
injecting
34 (79) 42 (81) 1.1 (0.4, 3.0) 39 (66) 55 (62) 0.8 (0.4, 1.7) 0.638 0.9 (0.5, 1.6) 0.745
Needed help injecting
(last six months)
19 (44) 23 (49) 1.2 (0.5, 2.8) 14 (24) 35 (39) 2.1 (1.0, 4.3) 0.337 1.6 (1.0, 2.8) 0.073
Needle lending (last 6
months)
10 (24) 14 (27) 1.2 (0.5, 3.0) 3 (5) 13 (15) 3.2 (0.9, 11.9) 0.211 1.7 (0.8, 3.7) 0.141
Ever borrowed used
needle
27 (47) 28 (41) 0.8 (0.4, 1.5) 22 (31) 27 (27) 0.8 (0.4, 1.6) 0.869 0.8 (0.5, 1.3) 0.348
Needle borrowing (last 6
months)
13 (30) 17 (33) 1.1 (0.5, 2.7) 8 (14) 13 (14) 1.0 (0.4, 2.7) 0.903 1.1 (0.6, 2.1) 0.814
Difficulty accessing clean
needles
16 (37) 20 (39) 1.1 (0.5, 2.4) 9 (16) 24 (27) 2.0 (0.9, 4.7) 0.287 1.5 (0.8, 2.6) 0.207
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Prince George Vancouver
Variable
Males
n (%)
Females
n (%)
Odds Ratio
(95% CI)
Males
n (%)
Females
n (%)
Odds Ratio
(95% CI)
Test for
Heterogeneity
Summary
Odds Ratio
(95% CI)
p
Value
On average, use the
same rig more than once
26 (61) 30 (58) 0.9 (0.4, 2.0) 18 (31) 23 (26) 0.7 (0.4, 1.6) 0.469 0.8 (0.5, 1.4) 0.470
Mobile needle exchange
use (last 6 months)
4 (9) 7 (14) 1.7 (0.5, 6.1) 26 (50) 61 (71) 2.3 (1.2, 4.8) 0.652 2.2 (1.2, 4.0) 0.016
Fixed needle exchange
use (last 6 months)
34 (76) 43 (83) 1.5 (0.6, 4.2) 21 (41) 47 (54) 1.7 (0.8, 3.3) 0.894 1.6 (0.9, 2.9) 0.092
Daily visit of any needle
exchange
11 (26) 21 (40) 2.0 (0.8, 4.8) 13 (23) 23 (26) 1.2 (0.5, 2.6) 0.406 1.5 (0.8, 2.7) 0.178
Ever been on methadone
maintenance treatment
5 (9) 19 (28) 4.0 (1.4, 11.4) 11 (15) 45 (46) 4.8 (2.2, 10.1) 0.776 4.5 (2.4, 8.3) <0.001
Currently in alcohol or
drug treatment program
21 (37) 22 (32) 0.8 (0.4, 1.7) 8 (11) 17 (17) 1.7 (0.7, 4.2) 0.208 1.1 (0.6, 1.9) 0.757
Tried but failed to access
drug treatment (last 6
months)
9 (16) 14 (20) 1.4 (0.5, 3.4) 10 (14) 16 (16) 1.2 (0.5, 2.8) 0.833 1.3 (0.7, 2.4) 0.466
Currently in methadone
treatment
2 (4) 5 (7) 2.1 (0.4, 11.5) 5 (7) 18 (18) 3.0 (1.1. 8.5) 0.742 2.7 (1.1, 6.6) 0.025
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252 WOMEN & HEALTH
TABLE 5. Prevalence of HIV and HCV Infection Among Female and Male
Cedar Project Participants Stratified by Injection Drug Use
HIV Prevalence (n D 538)
Group
Male
Prevalence (%)
[95% CI]
(# Infected/Total #)
Female
Prevalence (%)
[95% CI]
(# Infected/Total #)
Odds Ratio
(95% CI) p-Value
All participants 4.3 13.1 3.34 <0.001
[2.5, 7.4] [9.5, 17.7] (1.69, 6. 59)
12/278 34/260
Injectors (ever) 8.5 16.7 2.16 0.037
[4.8, 14.5] [11.8, 23.0] (1.03, 4.5)
11/130 28/168
Non-injectors (ever) 0.7 6.5 10.26 0.0142
[0, 3.7]1 [2.4, 13.7]1 (1.21, 86.62)
1/148 6/92
HCV Prevalence (n D 518)
All participants 25.4 43.6 2.27 <0.001
[20.5, 30.9] [37.6, 49.8] (1.57, 3.30)
68/268 109/250
Injectors (ever) 50.4 65.4 1.86 0.010
[41.8, 59.0] [57.8, 72.3] (1.56, 3.00)
63/125 106/162
Non-injectors (ever) 3.5 3.4 0.974 1.002
[1.1, 7.8]1 [0.7, 9.6]1 (0.23, 4.18)
5/143 3/88
1Exact Binomial Confidence Interval.
2Based on Fisher’s Exact Test.
Among non-injectors, the proportion of HIV positive was eight times
higher among females (6.5%) compared to males (0.7%), p D 0:014.
Multivariable Analysis
Using forward stepwise multiple logistic regression, living in Van-
couver vs. Prince George (unadjusted odds ratio [UOR]: 2.3, 95%
confidence Interval [CI] 1.1, 4.9), increased duration of injection drug
use as a continuous variable in months (UOR: 1.0, 95% CI: 1.01,
1.02), and ever having been sexually abused (UOR: 3.1, 95% CI:
1.4, 6.9) were independently associated with HIV infection (Table 1).
These variables were used to investigate the association of gender
with HIV seropositivity. When the model was built in a stepwise
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fashion beginning with gender, being female was significantly asso-
ciated with HIV seropositivity as seen in model 1. However, being
female was not significantly associated with HIV in the final model
(model 3). The final model included location, duration of infection,
and history of sexual abuse as significant independent variables related
to HIV infection. Inclusion of location and duration of infection did
not dramatically alter the odds ratio estimate for gender. However,
when sexual abuse was added to the model, the association with
being female on HIV was attenuated (model 3). Interactions terms
were tested in the model, specifically for being female, location of
residence, and having experienced sexual abuse, but no interaction
terms were found to be significant.
DISCUSSION
Indigenist scholars agree that the cumulative effects of historical
and lifetime trauma are related to the HIV epidemic among Aboriginal
women in North America (Walters & Simoni, 2002; Simoni, Sehgal,
& Walters, 2004). In this study, we found that young Aboriginal
women were three times more likely than men to be HIV positive.
When the analysis was restricted to participants who had ever injected
drugs at baseline, women were twice as likely to be HIV positive. In
addition, two-thirds of the young Aboriginal women in this study
who injected drugs were HCV positive at baseline, 30% higher than
young men, despite the fact that the women were slightly younger.
To our knowledge, this is the first study addressing gender-related
HIV vulnerability among young Aboriginal people who use drugs in
Canada.
Gender was not associated with HIV infection independent of sex-
ual abuse. While it is possible that the study was unable to detect
an independent effect due to the sample size being too small or to
measurement issues, this finding should not diminish the importance
of gender related to HIV vulnerability among young Aboriginal people
who use drugs. Indeed, because a greater number of women reported
having experienced sexual abuse, an uncritical use of gender may not
have highlighted the significance of women’s vulnerability to HIV.
It is widely accepted that sexual abuse in Aboriginal communities
was relatively rare prior to colonization, and traditional child protec-
tion mechanisms effectively enforced moral codes and cultural taboos
(Aboriginal Peoples Collection, 1997; Fournier & Crey, 1997; Hylton,
2002, p. 7). In the aftermath of European colonization, Aboriginal
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254 WOMEN & HEALTH
cultural principles that fostered a sacredness of sexuality were dis-
mantled, impacting preventative values and traditions (Chester, Robin,
Koss, Lopez, & Goldman, 1994). Consequently, sexual violence
among indigenous women in Canada, the U.S., and Australia have
reached epidemic proportions (Brownridge, 2003; Evans-Campbell,
Lindhorst, Huang, & Walters, 2006; Raphael, Swan, & Martinek,
1998; Walters & Simoni, 2002). An established body of literature has
addressed the healthcare needs of female survivors of sexual trauma
and focused upon high rates of substance abuse, depression, post-
traumatic stress syndrome injection drug use, sexual risk, and HIV
infection later in life (Miller, 1999; Simoni, Sehgal, & Walters, 2004;
Barker-Collo, 1999; Kue Young & Katz, 1998; Robin, Chester, Ras-
mussen, Jaranson, & Goldman, 1997; Wyatt et al., 2002; Pearce et al.,
2008). These findings have clear implications for clinicians, outreach
workers, and the criminal justice system. Health programming for
vulnerable populations, including women who use drugs, often ignores
the effects of sexual violence (Amaro, 1995; Craib et al., 2003; Duran
& Walters, 2004). Policies aimed at reducing HIV risk among Abo-
riginal women often fail to consider the psychological consequences
of imposed sexual activity that has roots in historical trauma (Walters
& Simoni, 1999; Pearce et al., 2008). Addressing the issue of sexual
trauma within Aboriginal families may require a dynamic multilevel
approach at the individual, family, organizational, community, and
policy levels (Oetzel & Duran, 2004; Pearce et al., 2008). Certainly, a
significant increase in resources to provide intensive healing programs
for victims, offenders, and their families must be supported by
leadership, chief and council, community-based health representatives,
addiction specialists, crown attorneys, and law enforcement (Duran &
Walters, 2004; Aboriginal Peoples Collection, 1997; Ross, 2006).
With the exception of crystal methamphetamine, the young Abo-
riginal women in this study were more likely to report more frequent
drug use for nearly every drug use category examined in univariate
analyses. Young women in this study were almost four times more
likely than men to report daily opiate use and seven times more likely
to report daily speedball use. Literature suggests that drug-dependent
women use opiates to mitigate the effects of physical and emotional
pain associated with early abuse experiences and survival sex work
(Miller et al., 2002). The HIV epidemic that has occurred in Vancouver
among people who use injection drugs has been related to needle shar-
ing, which is exacerbated by frequent use of injection cocaine (Tyndall
et al., 2003). However, pain associated with withdrawal in addition
to memories of trauma that emerge as the numbing effect of drug
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use subsides, makes it difficult for drug-dependent women to protect
themselves against HIV (Connors, 1994). In addition, women who
inject drugs and are in a relationship where there is an imbalance of
power are more vulnerable when they are going through withdrawal,
as they are more likely to accept sex without a condom and inject
second on the needle (Spittal et al., 2002).
Significant proportions of young Aboriginal women in this study
reported using opiates in the last six months, but only a fraction of
the women reported currently using methadone maintenance therapy
(MMT). Despite expansions in the availability of MMT in BC in
2000, and its demonstration of successful opiate addiction treatment
and HIV prevention (Gibson, Flynn, & McCarthy, 1999) physicians in
public health clinics in Vancouver have recently reported an inability
to meet patient demand (Buxton, 2007). Increased efforts should be
made to determine other barriers of MMT access among Aboriginal
women and to explore alternative therapies for opiate addiction where
MMT is not successful.
The HIV epidemic among Aboriginal people in Canada has been
predominantly associated with injection drug use; however, we found
that among Cedar Project participants who had never injected drugs,
women had a significantly higher HIV infection rate than men (M:F D
0.7%:6.5%). Although the proportion of HIV seropositivity was
comparatively lower than among participants who reported injection
drug use, this result suggests increased heterosexually acquired HIV
among young Aboriginal women. Significantly more young Aborig-
inal women in this study reported having regular partners of the
opposite sex and over 80% reported unsafe sex with their regular
partners. Unsafe sex among regular sexual partners has been reported
among men and women in the general population (PHAC, 1999)
and in a systemic review of condom use among Aboriginal people
(Devries, Free, & Jategaonkar, 2007). However, it should not be
assumed that young Aboriginal women in this study are negotiating
condom use with their regular partners in consensual circumstances
(Wyatt et al., 2002). Established literature has indicated that the
negotiating power of marginalized women for condom use is often
constrained by an imbalance of power in relationships and contextual
factors such as the fear of anger, violence, or abandonment from
their male partners (Amaro, 1995; Fenaughty, 2003). Violence in
relationships greatly reduces women’s ability to make safe sex choices
with their regular partners, and compounds existing factors, including
antecedent sexual abuse, unstable housing, and poverty (Vernon,
2001).
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The significantly higher percentage of young Aboriginal women in
this study who had injected in their lifetime is a cause for concern
(M:F D 47%:65%). Recently, in response to the increased HIV/HCV
prevalence in the north of BC, the Northern Aboriginal HIV/AIDS
Task Force implemented a mobile needle exchange van (Northwest
Tribal Treaty Nations, 2005). Further evaluation is necessary to ensure
that women surviving on the streets in this northern community are
accessing this critically important harm reduction initiative. Mean-
ingful involvement of young people who use drugs in the design of
injection prevention programming is urgently required.
Limitations to this study should be acknowledged. As a probability
sampling framework was not available for the population under study,
recruitment for the Cedar Study was non-random. Therefore, we can-
not discount the possibility that our recruitment method was biased
toward particularly vulnerable young Aboriginal men and women
using drugs. Further, we were not able to determine non-response
biases within the study. Our study was based on self-report; partici-
pants may under-report behaviors that are illegal or stigmatizing. Self-
reports of drug use have been found to be fairly reliable, however,
and valid when participants feel that confidentiality is assured and
that they are not judged. As study participants were aware of the
duty of the interviewer to report sexual abuse for those under the
age of 18, under-reporting of sexual abuse among participants under
18 years of age may have occurred. Gender differences between
men and women under age 18 and who reported sexual abuse were
not found; therefore, we do not believe this affected the direction
of the associations. Finally, this was a cross-sectional study, and
we were therefore unable to determine the temporality of variables
associated with HIV seropositivity. Due to the limited focus of the
population under study, generalizations cannot be made to the general
population of Aboriginal young people who reside in urban settings.
It is important to note that the comparison group of men was an
extremely vulnerable group themselves, and differences that did not
obtain statistical significance should not be considered as lacking
importance; rather, this population of young people was experiencing
similar conditions. Conversely, numerous statistical comparisons were
undertaken, thereby increasing the possibility of detecting associations
due to chance.
In summary, this study highlighted that, among a cohort of young
Aboriginal people who used injection and non-injection street drugs,
women were significantly more likely to be HIV positive among both
young people who used injection drugs and those who did not. The
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ity
 of
 W
es
ter
n O
nta
rio
] a
t 0
7:0
5 1
6 D
ec
em
be
r 2
01
2 
Mehrabadi et al. 257
high rates of traumatic life events reported by young women involved
in this study, including sexual abuse, attempted suicide, incarcera-
tion, survival sex work, and overdose are an indication that young
Aboriginal people are still grappling with multigenerational effects of
both the residential school and child welfare systems. In particular,
the high rate of lifetime sexual abuse and the very young median
age of first sexual abuse among young women in the Cedar Project
was one of the most distressing findings of this study, particularly in
light of its association with HIV infection. Young Aboriginal women
who are sexual abuse survivors must be afforded the opportunity to
provide leadership in the design and implementation of programming
for healing unresolved historical and lifetime grief.
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